Screening and Evaluation on Feasibility of Traditional Chinese Medicine for Remission Phase of Bronchial Asthma
- VernacularTitle:支气管哮喘缓解期中医药治疗的适宜性技术筛选研究
- Author:
Jinghua LI
1
;
Junwen WANG
;
Lili XU
;
Qi YU
;
Ling ZHU
;
Tong YU
;
Ye TIAN
;
Xiaofeng SUN
;
Zegeng LI
Author Information
- Keywords: Bronchial asthma; remission phase; treatment technology; TCM feasible technology; technology screening; technology evaluation
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2018;20(4):558-563
- CountryChina
- Language:Chinese
- Abstract: To screen and evaluate the TCM in the treatment of bronchial asthma. Methods Retrieved the journals from China National Knowledge Infrastructure, the Vip Database, Wanfang Data and the Chinese Biomedical Literature Database (Sino Med) . The time limitation ran from January 1, 1987 to December 31, 2016. Extracted the indicators of the assessment based on the evaluating and screening system of country feasible TCM technology. Results a total of 150 treatment techniques were screened.They mostly were Chinese compound formula or point-application therapy. The score was between 24.857 and 34.304. Application of evaluating and screening system of country feasible TCM technology can screen and evaluate the feasible technologiesin the treatment of remission phase of bronchial asthma.
